arrow
R

Rik J. Verheijden

University Medical Center Utrecht
H指数:13
被引数:900

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response

基于人工智能的病理组织学分析预测晚期黑色素瘤对检查点抑制剂的反应并识别与反应相关的模式

2026-05-250
OAAI
Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events

在检查点抑制诱导的免疫相关不良事件中,对类固醇无应答的血液和组织相关因素

2025-11-180
OA
Anti-PD-1 treatment response is associated with the influx of circulating myeloid and T-cell subsets into the metastatic melanoma tumor microenvironment

Anti-PD-1治疗反应与循环髓系细胞和T细胞亚群流入转移性黑色素瘤肿瘤微环境相关

2025-09-020
OAAI
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma
2024-08-014
PRE
A prediction model for response to immune checkpoint inhibition in advanced melanoma
2024-01-313
OA
BRAF/MEK inhibitor rechallenge in advanced melanoma patients
CANCER
IF5.1
2024-01-102
OAAI
Corticosteroids and second-line immunosuppressants for immune-related adverse events and melanoma survival
2023-10-011
OA
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma
2023-03-041
OA
Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1-Treated Patients in the Dutch Melanoma Treatment Registry
2020-05-01129
OAAI
Lower risk of severe checkpoint inhibitor toxicity in more advanced disease
2020-01-0115
OAAI